[COVID-19 infection in chronic dialysis patients in Argentina]

Liliana Bisigniano1, Guillermo Rosa-Diez2,3, Viviana Tagliafichi1

  • 1Instituto Nacional Central único Coordinador de Ablación e Implante (INCUCAI), Buenos Aires, Argentina.

Medicina
|December 7, 2021
PubMed

Insights

Patients on chronic dialysis in Argentina are highly vulnerable to COVID-19, with a 12x higher mortality rate than the general population. Priority vaccination and enhanced safety measures in dialysis units are crucial for this high-risk group.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic has disproportionately affected vulnerable populations.
  • Patients undergoing chronic dialysis are at increased risk for severe COVID-19 outcomes due to compromised immune systems and frequent healthcare interactions.

Purpose of the Study:

  • To report preliminary data on COVID-19 infection and mortality among patients on chronic dialysis in Argentina.
  • To identify risk factors associated with COVID-19 mortality in this patient cohort.

Main Methods:

  • Analysis of data from the Argentine Registry of COVID in chronic dialysis from April 2020 to April 2021.
  • Inclusion of all dialysis centers nationwide, covering 36,918 prevalent patients.
  • Multivariate analysis to determine factors associated with mortality.

Main Results:

  • 10% of prevalent dialysis patients (3709) contracted COVID-19.
  • 45.2% of infected patients required hospitalization, with 39% needing ICU admission and 62% of those requiring mechanical ventilation.
  • Overall mortality was 35.24%, which is 12 times higher than the general population. Key mortality factors included age >60, diabetes, longer dialysis duration, cerebrovascular disease, neoplasia, hospitalization, ICU admission, and mechanical ventilation.

Conclusions:

  • Patients on chronic dialysis in Argentina represent a highly vulnerable population susceptible to severe COVID-19 outcomes and elevated mortality.
  • Implementing stringent protective measures within dialysis units, optimizing patient care, and prioritizing vaccination are critical for mitigating COVID-19 impact in this group.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
143
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
604
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
179
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
104
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
136
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
134